Format

Send to

Choose Destination
Clin Calcium. 2018;28(8):1045-1050. doi: CliCa180810451050.

[Fragility Fractures in Hemodialysis Patients. Uremic bone disease:the effect of medical treatment until now.]

[Article in Japanese]

Author information

1
Division of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
2
Division of Nephrology, Kanto Rosai Hospital, Kawasaki, Japan.
3
Saiyu Clinic, Koshigaya, Japan.

Abstract

In the 1970s, severe osteoarticular lesion appeared to the patients from a relatively early stage after initiation of dialysis. It was recognized as dialysis osteodystrophy and was an important threat of the patients. The main causes of the lesion were osteitis fibrosa due to secondary hyperparathyroidism and osteomalacia including an aluminum bone disease. But it is now occasional to encounter these typical bone lesion by the development of subsequent active vitamin D preparation, a non-calcium-containing phosphate binder and calcimimetics, and the complete removal of aluminum from the dialysis field. However, ectopic calcification due to aplastic bone disease and the progression of osteoporosis with the aging population are the upcoming problems. To overcome these problems, researches for pathophysiology and mechanism, establishment of the management tools and the development of effective drug are expected.

PMID:
30049912
DOI:
CliCa180810451050
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center